Results 91 to 100 of about 370,474 (302)
STDs during pregnancy : CDC fact sheet [PDF]
If you are pregnant, you can become infected with the same sexually transmitted diseases (STDs) as women who are not pregnant. Pregnant women should ask their doctors about getting tested for STDs, since some doctors do not routinely perform these tests).core Maternal Flow-Mediated Dilation and Nitrite Concentration During Third Trimester of Pregnancy and Postpartum Period
, 2015 Objectives. To compare maternal flow-mediated dilation (FMD) of the brachial artery and nitrite concentration between third trimester of pregnancy (3rdT) and postpartum (PP) period.Amaral, LM, Teixeira, DM, Tanus-Santos, JE, Cavalli, RC, Machado, JSR, Sandrim, VC, Duarte, G, Miyague, AH, Martins, WP, Palei, AC, Sertorio, JTC +10 morecore +1 more sourceComprehensive Assessment of Arterial, Tissue, and Venous Collaterals for Evaluating the Infarct Growth Rate: The Multimodal Collateral Score
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Background
Collaterals are crucial factors that influence the infarct growth rate (IGR). We aimed to determine whether a comprehensive multimodal collateral score (MCS), incorporating collateral assessment at the arterial, tissue, and venous levels, is associated with functional independence and provides incremental prognostic value over ...Giorgio Busto, Umberto Pensato, Ilaria Casetta, Giorgio U. Marcello, Angelo Barra, Anna Poggesi, Edoardo Carlesi, Sara Mancini, Andrea Ginestroni, Vittorio Miele, Alessandro Padovani, Andrea Morotti, Enrico Fainardi +12 morewiley +1 more sourceEarly Clinical, Imaging, and Pathological Characteristics of SRPK3/TTN‐Digenic Myopathy
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective
SRPK3/TTN‐digenic myopathy was recently established as a skeletal muscle myopathy caused by digenic inheritance. This study characterizes the early clinical presentation of SRPK3/TTN‐digenic myopathy in one previously reported and seven newly identified pediatric patients.Rotem Orbach, Sandra Donkervoort, Carola Hedberg‐Oldfors, Giovanni Baranello, Dimah Saade, Precilla D'Souza, Ruchee Patel, Eva Michael, A. Reghan Foley, Diana Bharucha‐Goebel, S. Jin Haugland, Meghan McAnally, Omer Abdul Hamid, Katherine Chao, Ellen F. Macnamara, Alan H. Beggs, Anna Sarkozy, Juliane Mueller, Steven A. Moore, Richard S. Finkel, Cynthia J. Tifft, Francesco Muntoni, Anders Oldfors, Carsten G. Bönnemann +23 morewiley +1 more sourceEfficacy of Inebilizumab in N‐MOmentum Trial Participants With or Without Prior Immunosuppressants
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT
This post hoc analysis examined the impact of prior immunosuppressants on the long‐term efficacy and safety of inebilizumab, a cluster of differentiation 19+ B‐cell–depleting monoclonal antibody, in participants with aquaporin‐4–seropositive neuromyelitis optica spectrum disorder from the N‐MOmentum trial (NTC02200770).Bruce A. C. Cree, Beatrice Suero, Sarah Walsh, Romain Marignier, John W. Lindsey, Ho Jin Kim, Dewei She, Daniel Cimbora, Dustin Cavida, Friedemann Paul +9 morewiley +1 more sourcePlasma EV Proteomics Identifies ECM Remodeling and Inflammatory Proteins LUM and C7 as Candidate Biomarkers in FSHD
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective
Facioscapulohumeral muscular dystrophy (FSHD) is one of the most debilitating and common muscular dystrophies. Despite its severity, no approved therapy exists for FSHD patients. However, several therapeutic candidates are currently under development, and some have recently entered clinical trials, marking the need for reliable ...Mustafa Bilal Bayazit, Chiranth K. Nagaraj, Jackson S. Newell, Kim Truc Nguyen, Xilal Y. Rima, Jacob Doon‐Ralls, Eduardo Reátegui, Jeffrey M. Statland, Rabi Tawil, Kevin M. Flanigan, Scott Q. Harper, Nizar Y. Saad +11 morewiley +1 more sourceA risk prediction model for the assessment and triage of women with hypertensive disorders of pregnancy in low-resourced settings: the miniPIERS (Pre-eclampsia Integrated Estimate of RiSk) multi-country prospective cohort study.
, 2014 BACKGROUND: Pre-eclampsia/eclampsia are leading causes of maternal mortality and morbidity, particularly in low- and middle- income countries (LMICs). We developed the miniPIERS risk prediction model to provide a simple, evidence-based tool to identify ...Jennifer A Hutcheon, Haniff Farizah, Jing Li (10611), Haniff, F, Qu, Z, Steyn, DW, D Wilhelm Steyn, Grobman, WA, Hall, David R., Jennifer A. Hutcheon (368523), Annettee Nakimuli (512186), Zulfiqar A. Bhutta (121489), Mariana Widmer (232499), Bhutta Shereen Z., Shereen Z Bhutta, Bhutta, ZA, miniPIERS Study Working Group, Farizah Haniff (512184), Shereen Z. Bhutta (512181), Widmer, M, Bhutta, Shereen Z., Ansermino, J. Mark, Diane Sawchuck (512189), Sawchuck Diane, Steyn, D. Wilhelm, Groen, Henk, Hall, DR, von Dadelszen Peter, Payne, Beth A., Henk Groen, Steyn D. Wilhelm, Nakimuli, A, Widmer, Mariana, Rozina Sikandar, Biryabarema, Christine, von Dadelszen, Peter, D. Wilhelm Steyn (512190), Merialdi, M, Laura A. Magee (512185), Magee Laura A., Qu, Ziguang, Peter von Dadelszen, Zhou Jian, Dadelszen, Peter von, David R. Hall (106818), MiniPIERS Study Working Grp, Sass, Nelson [UNIFESP], Grobman, William A., Widmer Mariana, Hutcheon, Jennifer A., Sikandar Rozina, Bhutta, Zulfiqar A., Rozina Sikandar (512188), Beth A Payne, Biryabarema, C, Annettee Nakimuli, Nakimuli, Annettee, Bhutta Zulfiqar A., Ansermino, JM, Grobman William A., Sikandar, Rozina, Ziguang Qu, Payne Beth A., Zhou, Jian, Henk Groen (444146), Sikandar, R, Zulfiqar A Bhutta, Groen Henk, Jian Zhou (28020), Magee, Laura A., Jian Zhou, Sass Nelson, Groen, Henk; id_orcid, Merialdi Mario, Jing Li, Li Jing, Zhou, J, von Dadelszen, P, Mario Merialdi (164060), William A Grobman, Bhutta, Zulfiqar Ahmed, Sawchuck, Diane, Hutcheon Jennifer A., Mario Merialdi, Payne, BA, Sawchuck, D, Nelson Sass, ?, ?, Hutcheon, JA, Merialdi, Mario, Biryabarema Christine, Hall David R., Ziguang Qu (512187), Nakimuli Annettee, Li, J, J Mark Ansermino, Qu Ziguang, Christine Biryabarema (512182), J. Mark Ansermino (426355), Farizah Haniff, Mariana Widmer, Bhutta, SZ, Beth A. Payne (512180), Haniff, Farizah, David R Hall, Groen, H, Nelson Sass (346028), Ansermino J. Mark, Sultanali, Rozina Sikandar, Li, Jing, Christine Biryabarema, Diane Sawchuck, von Dadelszen, Peter; id_orcid, Sass, Nelson, Sass, N, Peter von Dadelszen (258508), Magee, LA, William A. Grobman (512183), Laura A Magee +118 morecore +1 more sourceOnasemnogene Abeparvovec in Patients With SMA: Interim Results of the RESTORE Registry in Japan
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective
There are limited real‐world data regarding the safety and effectiveness of onasemnogene abeparvovec (OA; Zolgensma) infusion, a one‐time gene replacement therapy, for Japanese patients with spinal muscular atrophy (SMA). We aimed to improve understanding of the real‐world outcomes for OA in Japan.Kayoko Saito, Kamal Benguerba, Ken Tsuchida, Kazushige Yazawa, Isao Tsumiyama, Hiromitsu Kayama, Sandra P. Reyna, Farid Khan, Richard S. Finkel +8 morewiley +1 more source